DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for MEI Pharma, Inc. (MEIP)
« Back to company indexMEIP Chatter Timeline
Stock Ticker for MEIP
Most Active Tweeters for MEIP
| User | Tweets |
|---|---|
| @AmericanBanking | 4 |
| @MrHypeMind | 3 |
| @StockWatchHQ | 2 |
| @dispatchtribune | 2 |
| @dailypoliticaln | 2 |
Recent Tweets for MEIP
 |
@newswelldone $MEIP: MEI Pharma: Time To Reload At Key Support Level: https://t.co/N3LpQ49BT5 June 16th 2019, 8:06am |
 |
@OLEGEFF $MEIP - MEI Pharma: Time To Reload At Key Support Level https://t.co/yiPNS1iJMt June 16th 2019, 8:06am |
 |
@SeekingAlpha $MEIP - MEI Pharma: Time To Reload At Key Support Level https://t.co/Sk2BqpoBwr June 16th 2019, 8:06am |
 |
@dispatchtribune MEI Pharma Inc $MEIP Receives Consensus Recommendation of “Buy” from Analysts https://t.co/AZ1hT6uUTH June 16th 2019, 2:06am |
 |
@AmericanBanking MEI Pharma Inc $MEIP Given Consensus Rating of “Buy” by Brokerages https://t.co/KYb9bg6zQj #stocks June 16th 2019, 2:06am |
|
@dispatchtribune Brokerages Expect MEI Pharma Inc $MEIP Will Post Quarterly Sales of $1.05 Million https://t.co/FtFApX2qQn June 15th 2019, 7:06pm |
 |
@Gambiste1 RT @CostanzTrade: $MEIP 2.55 bounce spot June 12th 2019, 6:06pm |
 |
@CostanzTrade $MEIP 2.55 bounce spot June 12th 2019, 11:06am |
 |
@OlympiaReport Zacks: Brokerages Anticipate MEI Pharma Inc $MEIP to Announce -$0.20 EPS https://t.co/YRl5VNdSF1 June 11th 2019, 12:06pm |
 |
@WeekHerald $1.05 Million in Sales Expected for MEI Pharma Inc $MEIP This Quarter https://t.co/NARklIlZaC June 11th 2019, 12:06pm |
 |
@stocknewstimes MEI Pharma $MEIP Rating Reiterated by HC Wainwright https://t.co/CB7wZu7ZyE June 11th 2019, 3:06am |
 |
@SleekMoneycom MEI Pharma $MEIP Rating Reiterated by HC Wainwright https://t.co/3FyVOKubHD #investing June 11th 2019, 3:06am |
 |
@storminvestor MEI Pharma $MEIP Rating Reiterated by HC Wainwright https://t.co/kJG5YlS1mb #markets June 11th 2019, 3:06am |
 |
@buffettvalue My position in $MEIP is getting hit. Need to see what is going on with it tonight or if just volatility. Bought a… https://t.co/NdmX72nZPl June 10th 2019, 5:06pm |
|
@MrHypeMind Big volume today.. $MEIP something going on? June 10th 2019, 3:06pm |
 |
@bbnsnews MEI Pharma’s $MEIP Buy Rating Reaffirmed at HC Wainwright https://t.co/BHEM40e8HD June 10th 2019, 4:06am |
 |
@TranscriptDaily HC Wainwright Reaffirms “Buy” Rating for MEI Pharma $MEIP https://t.co/z63kotPJGJ June 9th 2019, 8:06am |
 |
@dailypoliticaln MEI Pharma $MEIP Stock Rating Reaffirmed by HC Wainwright https://t.co/9Ctv0bQKJ5 June 8th 2019, 9:06am |
|
@dailypoliticaln MEI Pharma Inc $MEIP Expected to Post Quarterly Sales of $1.05 Million https://t.co/8MHg61KusC June 8th 2019, 2:06am |
|
@AmericanBanking Brokerages Expect MEI Pharma Inc $MEIP Will Announce Quarterly Sales of $1.05 Million https://t.co/HmkUfEC76Q #stocks June 8th 2019, 2:06am |
|
@AmericanBanking MEI Pharma’s $MEIP Buy Rating Reaffirmed at HC Wainwright https://t.co/dS2Yv803VN #stocks June 7th 2019, 10:06am |
 |
@StockWatchHQ RT @StockWatchHQ: MEI Pharma $MEIP To Be Purchased By Celgene Corp. $CELG in Stock and Cash Transaction, Announcement Pending https://t.co/… June 6th 2019, 4:06pm |
 |
@macondailynews -$0.20 Earnings Per Share Expected for MEI Pharma Inc $MEIP This Quarter https://t.co/wy9NGIbasM June 6th 2019, 12:06pm |
|
@AmericanBanking MEI Pharma Inc $MEIP Expected to Announce Earnings of -$0.20 Per Share https://t.co/YLQo2XC01l #stocks June 6th 2019, 12:06pm |
|
@StockWatchHQ MEI Pharma $MEIP To Be Purchased By Celgene Corp. $CELG in Stock and Cash Transaction, Announcement Pending… https://t.co/7aKnsKfBBJ June 5th 2019, 11:06pm |
|
@MrHypeMind @TomSilver39 The is plenty of great news this week about $MEIP, but stock is diving.. weird. June 5th 2019, 5:06pm |
 |
@TomSilver39 " $MEIP The company recently hired the physician who ran the global registration trials for Bayer’s PI3K inhibitor… https://t.co/qTPDpxLF6a June 5th 2019, 3:06pm |
|
@TomSilver39 WF:" believes that $MEIP single agent ME-401 data in 3rd line ALL are as good as high-cost REVLIMID/RITUXAN combina… https://t.co/2we2dJzRco June 5th 2019, 3:06pm |
|
@MrHypeMind Any more news this week? $MEIP June 4th 2019, 8:06pm |
 |
@RobinDavison2 RT @TomSilver39: $meip #ASCO19 Poster; Results of the PI3K? Inhibitor ME-401 Alone or with Rituximab in Relapsed/Refractory (R/R) Follicul… June 4th 2019, 8:06am |
 |
@fintel_io Also, if you are new to $MEIP here's some background for you https://t.co/GuAJLS2FiQ June 3rd 2019, 4:06pm |
|
@fintel_io $MEIP / MEI Pharma files form 8-K https://t.co/hKCqD4tPeN - Financial Statements and Exhibits, Other Events June 3rd 2019, 4:06pm |
 |
@Stock_News_Now $MEIP: New SEC Filing for MEIP: Form 8-K (No. 0001193125-19-164088): https://t.co/RumNNe0dnm June 3rd 2019, 4:06pm |
|
@TomSilver39 $meip #ASCO19 Poster; Results of the PI3K? Inhibitor ME-401 Alone or with Rituximab in Relapsed/Refractory (R/R) F… https://t.co/LKhZ8zWb5L June 3rd 2019, 11:06am |
 |
@StockNewsNow $MEIP MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase… https://t.co/ujY23BUc6H June 3rd 2019, 11:06am |
 |
@Briefingcom $MEIP: MEI Pharma: Updated data from Phase 1b study of investigational ME-401 demonstrate an 80% overall response... https://t.co/vvwr3AeMyv June 3rd 2019, 11:06am |
 |
@NewsToDesk $MEIP: MEI Pharma Presents Updated Clinical Data from the ME-401 …: https://t.co/K1nCnmaYoL June 3rd 2019, 9:06am |
 |
@DZalkowitz $MEIP good data; way too cheap June 3rd 2019, 9:06am |
 |
@BioStocks $MEIP Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase 1b study i… https://t.co/8O365DecDK June 3rd 2019, 9:06am |
 |
@iluvstocks1 $MEIP : MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab P… https://t.co/Kk64PZppQl June 3rd 2019, 9:06am |
|
@Briefingcom $MEIP: MEI Pharma presents data from investigator-initiated study of investigational ME-344 in combination with... https://t.co/aPTawI9U2q June 3rd 2019, 8:06am |
 |
@HottestStockNow $MEIP Reveals Clinical Findings for Combo ME-344 + Bevacizumab in Early HER2 Negative Breast Cancer Patients https://t.co/tqa2dEuWIw June 2nd 2019, 5:06pm |
|
@HottestStockNow $MEIP to Present a Corporate Overview at Upcoming Conference https://t.co/tqa2dEuWIw June 2nd 2019, 5:06pm |
 |
@damnitfeelsgood RT @ToothFrank: $MEIP MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer… June 2nd 2019, 3:06am |
 |
@ToothFrank $MEIP MEI Pharma Presents Clinical Results for ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast… https://t.co/X2N6Aqew3u June 2nd 2019, 2:06am |
|
@TomSilver39 $MEIP #ASCO19 Poster: ME-344 in Combination with Bevacizumab in Early HER2 Negative Breast Cancer https://t.co/7mCn3R0H7l June 1st 2019, 8:06pm |
 |
@1stOncology #MEI Pharma to Present at the Jefferies 2019 Global #HealthcareConference $MEIP https://t.co/pQ7L31RYJE June 1st 2019, 4:06am |
|
@StockNewsNow $MEIP MEI Pharma to Present at the Jefferies 2019 Global Healthcare Conference https://t.co/W4gNaRXwFv May 31st 2019, 11:05am |
 |
@TheMarketsDaily MEI Pharma Inc $MEIP Given Average Recommendation of “Buy” by Analysts https://t.co/pM4OJPMCgn May 29th 2019, 2:05pm |
|
@dakotafinancial MEI Pharma Inc $MEIP Given Consensus Recommendation of “Buy” by Brokerages https://t.co/lG8f8Lgobu May 27th 2019, 12:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.